Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Clinical trial NCT07479797 · RECRUITING
Trial details
- NCT number
- NCT07479797
- Sponsor
- Kite, A Gilead Company
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2031-05-01
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.